Treating Patients With Renal Impairment and Altered Glucose MetAbolism With TherapeutIc Carbohydrate Restriction and Sglt2-Inhibiton - a Pilot Study

Conditions: Chronic Kidney Diseases; Diabetes Mellitus; PreDiabetes; Overweight and Obesity Interventions: Behavioral: Therapeutic carbohydrate restriction combined with an SGLT-2-Inhibitor Sponsors: Department of Nephrology Clinic Ottakring Vienna Recruiting

https://clinicaltrials.gov/study/NCT06094231

Source: ClinicalTrials.gov - October 23, 2023 Category: Research Source Type: clinical trials